Reaction

Insulin-Like Growth Factor Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,414 reports · 13 co-occurring drugs

As of the last recalculation, Insulin-Like Growth Factor Increased appears in 1,414 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is LANREOTIDE ACETATE (PRR 201.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Lanreotide Acetate100201.9204.6
Octreotide Acetate293177.3179.0
Somatropin386106.0106.6
Liothyronine Sodium2237.837.9
Testosterone4227.227.3
Candesartan Cilexetil4324.824.8
Primidone1521.921.9
Hydrocortisone Sodium Succinate1117.417.4
Hydrocortisone9316.316.4
Testosterone Cypionate914.914.9
Tamsulosin Hydrochloride1611.711.7
Anastrozole Tablets1510.410.4
Atomoxetine Hydrochloride1610.010.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.